Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers

• Bulbulgul Aumakhan ,

  * E-mail: baumakhan@hivresearch.org

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Charlotte A. Gaydos,

  Affiliation Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Thomas C. Quinn,

  Affiliations Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Chris Beyrer,

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Lorie Benning,

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Howard Minkoff,

  Affiliation Maimonides Medical Center and SUNY Downstate, Brooklyn, New York, United States of America

  ⨯
• Daniel J. Merenstein,

  Affiliation Georgetown University Medical Center, Washington, D. C., United States of America

  ⨯
• Mardge Cohen,

  Affiliation Cook County Medical Center, Chicago, Illinois, United States of America

  ⨯
• Ruth Greenblatt,

  Affiliation Schools of Pharmacy and Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Marek Nowicki,

  Affiliation University of Southern California, Los Angeles, California, United States of America

  ⨯
• Kathryn Anastos,

  Affiliation Albert Einstein College of Medicine, Bronx, New York, United States of America

  ⨯
• Stephen J. Gange

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯